US SEC Filings Daily Market Digest — June 08, 2026

08-06-2026

GoHealth, Inc. has initiated a voluntary prepackaged Chapter 11 bankruptcy process to restructure its balance sheet, supported by 100% of its lenders, over 60% of Class A common stockholders, and over 99% of GoHealth Holdings, LLC interest holders. The company expects to continue operations without interruption and emerge before the 2026 annual enrollment period, with ownership transitioning to certain lenders. However, the restructuring will result in the delisting of Class A common stock from Nasdaq, and existing common equity holders will receive only limited recovery, reflecting a significant loss of value for shareholders.

• · The restructuring will reinstate preferred equity of GoHealth, Inc. and provide payment in full for trade payables and other ordinary course obligations.
• · A cash payment will be provided to holders of GoHealth common equity, though the amount is not specified.
• · The company expects Class A common stock to be delisted from Nasdaq and subsequently quoted on the OTCQB Basic Market or another over-the-counter market.
• · GoHealth has filed customary motions with the Bankruptcy Court to maintain uninterrupted operations and pay vendors and suppliers in full.
• · The restructuring is expected to be completed before the start of the 2026 annual enrollment period (AEP).

08-06-2026

Alpha Modus Holdings, Inc. filed an 8-K on June 8, 2026, announcing a 1-for-40 reverse stock split of its common stock, effective June 15, 2026, subject to Nasdaq approval. The reverse split does not change the authorized share count and fractional shares will be rounded up. The amendment was adopted by the board and stockholders.

• · Reverse stock split ratio is 1-for-40.
• · Effective time is the later of 7:00 a.m. New York Time on June 15, 2026, or Nasdaq approval and processing.
• · No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share.
• · Authorized share count remains unchanged.
• · Certificate of Amendment was signed on June 3, 2026.

08-06-2026

United States Antimony Corp (UAMY) filed a proxy supplement (DEFA14A) on June 8, 2026, amending Proposal No. 3 for its upcoming Annual Meeting on June 12, 2026. The amendment is due to the acquisition of the company's previously appointed independent auditor, Assure CPA, LLC, by Sadler Gibb & Associates, LLC, effective June 3, 2026. Shareholders are now asked to ratify the appointment of Sadler Gibb as the successor independent registered public accounting firm for fiscal year 2026, with no change to previously submitted votes.

• · The change in auditor resulted from Assure CPA, LLC being acquired by Sadler Gibb & Associates, LLC on June 3, 2026.
• · The lead engagement partner and professional staff responsible for prior audits have continued with Sadler Gibb and remain unchanged.
• · Proxies previously submitted for Proposal No. 3 will be voted 'FOR', 'AGAINST', or 'ABSTAIN' on the ratification of Sadler Gibb accordingly.
• · Representatives of Sadler Gibb are expected to attend the Annual Meeting and may make a statement.
• · The proxy supplement does not change any other proposals or the board's recommendations.

08-06-2026

CKX Lands, Inc. filed an 8-K on June 8, 2026, furnishing a press release that provides an update on its previously announced process to evaluate strategic alternatives. The filing does not disclose any financial results or specific milestones, and no material financial figures or performance metrics are included.

• · The press release was issued on June 8, 2026, and is attached as Exhibit 99.1.
• · The information is furnished under Regulation FD and is not deemed filed for Section 18 liability purposes.
• · The filing does not contain any financial statements or quantitative updates.

08-06-2026

Esperion Therapeutics, Inc. (ESPR) is soliciting stockholder approval for a merger agreement under which the company will be acquired by an affiliate of ARCHIMED, a healthcare-focused investment firm, for $257.7 million (based on 257,693,347 outstanding shares at $1.00 per share). The special meeting is scheduled for July 8, 2026. The Board unanimously recommends voting FOR the merger, the advisory compensation proposal, and the adjournment proposal. However, the merger is subject to stockholder approval, and the advisory compensation vote is non-binding and will not affect payment of executive compensation if the merger is approved.

• · The special meeting will be held virtually on July 8, 2026 at 8:00 a.m. Eastern Time.
• · Record date for voting is May 28, 2026.
• · Approval of the merger agreement requires the affirmative vote of a majority of outstanding shares.
• · Abstentions, failures to vote, and broker non-votes will have the same effect as a vote AGAINST the merger proposal.
• · The advisory compensation proposal is non-binding and will not affect payment of executive compensation if the merger is approved.
• · The Board unanimously recommends voting FOR all three proposals.
• · Parent and MergerCo were formed on April 21, 2026, specifically for this transaction.

08-06-2026

Verra Mobility Corporation announced the formation of a Transformation Committee of the Board on June 5, 2026, to oversee the company's transformation initiative aimed at better positioning the business for long-term growth. The committee will support management in reviewing business and financial strategies, cost optimization, growth opportunities, capital allocation, portfolio composition, and financing activities. The committee is chaired by Raj Ratnakar and includes Douglas Davis and John Rexford. No financial details or performance comparisons were provided in the filing.

08-06-2026

Skillz Inc. announced it will change its corporate name to 'Firy Inc.' effective June 18, 2026, with its Class A common stock trading under the new ticker symbol 'FIRY' on the NYSE starting June 22, 2026. The company also released limited information on reorganized business segments via an attached exhibit. No action is required from existing stockholders, and the CUSIP will remain unchanged.

• · Name change effective date: June 18, 2026
• · New ticker symbol 'FIRY' trading begins June 22, 2026
• · CUSIP remains unchanged
• · Exhibit 99.1 includes selected slides on reorganized business segments

08-06-2026

Ares Capital Corporation (ARCC) announced the establishment of its inaugural $1 billion commercial paper program, allowing issuance of short-term unsecured notes to reduce funding costs. The program is backstopped by the company's $5.5 billion Revolving Credit Facility, and proceeds will be used for general corporate purposes. No negative or flat metrics are present in this filing.

• · The commercial paper notes are unsecured and rank pari passu with the company's other senior unsecured indebtedness.
• · The notes will not be registered under the Securities Act of 1933 and are offered only through definitive offering documentation.
• · Ares Capital was the largest publicly traded BDC by market capitalization as of March 31, 2026.
• · The company was founded in 2004 and is externally managed by a subsidiary of Ares Management Corporation.

08-06-2026

On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Capital Management LLC and its affiliates, including his role as a member of the Board of Managers, effective August 3, 2026. The Managing Owner is considering a replacement. This filing is a routine disclosure of a director/officer departure with no financial impact.

• · Resignation effective date: August 3, 2026.
• · The resignation covers all positions at the Managing Owner and its affiliates.
• · The Managing Owner is currently considering a replacement.

08-06-2026

MSD Investment Corp. amended its Senior Secured Credit Agreement to increase the limit on Shorter Term Unsecured Indebtedness from $200,000,000 to $600,000,000, tripling the allowable amount. The amendment, effective June 5, 2026, was executed with JPMorgan Chase as administrative agent and a syndicate of lenders including Goldman Sachs, Deutsche Bank, Morgan Stanley, and others. The filing does not disclose any negative or flat performance metrics, but the increased debt capacity may signal higher leverage or growth financing needs.

• · The amendment also corrected a reference from 'HSBC Bank USA' to 'HSBC Bank USA, N.A.' in the existing credit agreement.
• · The amendment was governed by New York law and included a jury trial waiver.
• · No Default or Event of Default existed immediately prior to or after the amendment effective date, as represented by the borrower.

08-06-2026

At nLIGHT, Inc.'s 2026 annual meeting held on June 5, 2026, shareholders elected Geoffrey Moore as a Class II director and ratified KPMG LLP as the independent auditor for fiscal year 2026. However, in a non-binding advisory vote, shareholders did not approve named executive officer compensation, with 24,647,654 votes against versus 15,842,169 in favor.

• · Geoffrey Moore was elected as Class II director with 22,884,069 votes for and 18,307,711 withheld, plus 8,653,773 broker non-votes.
• · Ratification of KPMG LLP as independent auditor passed with 48,294,544 for, 1,466,757 against, and 84,252 abstentions.
• · The advisory vote on executive compensation failed: 15,842,169 for, 24,647,654 against, 701,957 abstentions, and 8,653,773 broker non-votes.
• · The annual meeting was held on June 5, 2026, and the proxy statement was filed on April 24, 2026.

08-06-2026

AVITA Medical, Inc. issued a warrant to Perceptive Credit Holdings V, LP on June 5, 2026, following stockholder approval at the 2026 Annual Meeting on June 3, 2026. The warrant allows Perceptive to purchase up to 500,000 shares of common stock at $3.4019 per share, with an additional 150,000 shares vesting if the Company draws the $10 million Additional Commitment Amount under the existing $60 million credit facility. The warrant shares are registered under the Company's existing S-3 registration statement.

• · The warrant exercise price is $3.4019 per share.
• · The warrant shares are registered under Registration Statement on Form S-3 (File No. 333-294790) with a prospectus supplement filed on June 5, 2026.
• · The Additional Commitment Amount of $10 million is subject to a net revenue requirement and must be drawn by March 31, 2027.
• · The Credit Agreement was originally entered into on January 13, 2026.

08-06-2026

Strive, Inc. (ASST) filed an 8-K on June 5, 2026, announcing amendments to its Series A Perpetual Preferred Stock (SATA) certificate of designation to increase authorized shares to 40,000,000, and entered into amended and restated sales agreements with multiple agents to sell up to $2.55 billion of Common Stock and up to $2.6 billion of SATA Stock through at-the-market offerings. The company also added several new sales agents, including Barclays Capital Inc., Clear Street LLC, The Benchmark Company, LLC, StoneX Financial Inc., B. Riley Securities, Inc., Maxim Group LLC, and H.C. Wainwright & Co., LLC. No financial results or period-over-period comparisons are provided in this filing.

• · The Certificate of Amendment for SATA Stock was filed with the Nevada Secretary of State on June 5, 2026, and is effective June 5, 2026, for the first amendment and June 15, 2026, at 12:01 am PT for the second amendment.
• · The A&R ASST Sales Agreement adds Barclays Capital Inc., Clear Street LLC, The Benchmark Company, LLC, StoneX Financial Inc., B. Riley Securities, Inc., Maxim Group LLC, and H.C. Wainwright & Co., LLC as additional agents alongside Cantor Fitzgerald & Co.
• · The A&R SATA Sales Agreement adds The Benchmark Company, LLC, StoneX Financial Inc., B. Riley Securities, Inc., Maxim Group LLC, and H.C. Wainwright & Co., LLC as additional agents alongside the original agents (Cantor Fitzgerald & Co., Barclays Capital Inc., Clear Street LLC).
• · The legal opinions of Brownstein Hyatt Farber Schreck, LLP regarding the validity of the shares are filed as Exhibits 5.1 and 5.2.

08-06-2026

loanDepot, Inc. held its 2026 Annual Meeting of Stockholders on June 4, 2026, where shareholders elected three Class II directors (Andrew Dodson, Steven Ozonian, and Pamela Patenaude), ratified the appointment of Ernst & Young LLP as independent auditor for fiscal year 2026, and approved, on a non-binding advisory basis, the compensation of named executive officers. All proposals passed with strong shareholder support, though broker non-votes were significant on the director elections and say-on-pay vote.

• · All three director nominees were elected with substantial majorities: Andrew Dodson received 236,408,220 votes for (94.7% of votes cast), Steven Ozonian received 241,227,416 for (96.6%), and Pamela Patenaude received 234,590,107 for (94.0%).
• · Ratification of Ernst & Young LLP passed with 297,662,063 votes for (97.9% of votes cast), 6,254,032 against, and 385,776 abstentions.
• · The non-binding advisory vote on executive compensation passed with 238,963,889 votes for (95.8% of votes cast), 10,549,037 against, and 125,985 abstentions.
• · Broker non-votes totaled 54,689,960 on the director elections and say-on-pay proposal, representing approximately 18% of total shares outstanding.

08-06-2026

Nauticus Robotics, Inc. filed an amendment to its Form 8-K to disclose that shareholders approved an amendment to the 2022 Omnibus Incentive Plan at the May 27, 2026 Annual Meeting, increasing the number of shares available for issuance to 6,000,000. The amendment became effective immediately following the meeting. No financial results or period-over-period comparisons were provided in this filing.

• · The amendment to the Plan was previously approved by the Board of Directors, subject to shareholder approval at the Annual Meeting.
• · A detailed summary of the Plan, as amended, is available on pages 30-35 of the Company's definitive proxy statement filed on April 17, 2026.
• · The full text of the amended Plan is attached as Exhibit 10.1 to this Form 8-K/A.

08-06-2026

On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Capital Management LLC and its affiliates, including his role on the Board of Managers of the Managing Owner, effective August 3, 2026. The Managing Owner is currently considering his replacement. No financial impact or performance data is disclosed in this filing.

• · Resignation effective date: August 3, 2026
• · Filing date: June 8, 2026
• · Event date: June 4, 2026
• · The Managing Owner is actively considering a replacement for Mr. Krugman

08-06-2026

On June 4, 2026, Jordan Krugman notified Invesco Galaxy Bitcoin ETF (BTCO) of his resignation from all positions at the Sponsor, Invesco Capital Management LLC, including his role on the Board of Managers, effective August 3, 2026. The Sponsor is currently considering a replacement. No financial impact or performance data is included in this filing.

• · Resignation effective date: August 3, 2026.
• · Filing date: June 8, 2026; event date: June 4, 2026.
• · Registrant is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

08-06-2026

On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC (the Sponsor) and its affiliates, including his role on the Board of Managers, effective August 3, 2026. The Sponsor is currently considering a replacement. No financial metrics or performance data are included in this filing.

• · Resignation effective date: August 3, 2026.
• · Filing date: June 8, 2026; event date: June 4, 2026.
• · Sponsor is actively considering a replacement for Mr. Krugman.

08-06-2026

Lennar Corporation announced the appointment of Jim Parker as Chief Operating Officer and David Grove as Executive Vice President, Homebuilding, effective immediately. Both executives bring 30 years of industry experience and will continue to report to Stuart Miller, Executive Chairman, CEO and President.

• · Jim Parker joined Lennar through the 2018 merger with CalAtlantic Homes.
• · David Grove has spent his entire career with Lennar since 1999, starting as a Construction Area Manager in Austin.
• · Both executives previously served as Area Presidents leading East and West operations respectively.
• · Lennar was founded in 1954 and is one of the nation's largest homebuilders.

08-06-2026

BGSF, Inc. filed an 8-K on June 5, 2026, to disclose an updated investor slide presentation that will be used in meetings with investors. The filing is a Regulation FD disclosure and does not contain any financial results or material changes to the company's operations.

• · The investor presentation is dated June 5, 2026, and is attached as Exhibit 99.1.
• · The presentation is available on the company's website at www.bgsf.com.
• · The information is furnished, not filed, under the Exchange Act and is not incorporated by reference into any SEC filings unless expressly stated.

08-06-2026

Silver Star Properties REIT, Inc. filed for Chapter 11 bankruptcy on May 28, 2026, along with its subsidiary Silver Star Virginia Parkway, LLC. The company is the guarantor of four loan agreements currently in default, with outstanding principal amounts of $24,599,690, $15,530,000, $17,000,000, and $8,100,000. Additionally, a promissory note of $5,750,000 is in default and the related property has been posted for foreclosure.

• · The Chapter 11 cases are filed in the United States Bankruptcy Court for the Northern District of Texas under case numbers 26-42316-mxm11 (Silver Star) and 26-42315-mxm11 (McKinney Debtor).
• · The McKinney Debtor's promissory note matures on June 7, 2026, and the lender has posted the storage property for foreclosure on June 2, 2026.
• · The company issued a press release on June 5, 2026, announcing the bankruptcy filing and its strategic path forward.

08-06-2026

Energy Recovery, Inc. held its 2026 Annual Meeting on June 4, 2026, with 85.3% of shares represented. All five director nominees were elected, with support ranging from 84.5% to 95.2%. The non-binding advisory vote on executive compensation was approved with 83.3% for, but 14.6% against. The ratification of Deloitte & Touche as auditor was overwhelmingly approved (99.3%). However, the approval of Amendment No. 1 to the 2020 Incentive Plan was narrowly passed with only 53.5% for and 44.9% against, indicating significant shareholder opposition.

• · David Moon resigned as President, CEO and director effective May 26, 2026, and did not stand for re-election.
• · Board size remains at 6 members with one vacancy.
• · Broker non-votes were 4,841,120 for all director elections and Proposals 2 and 4.
• · Proposal 4 (incentive plan amendment) had 44.9% votes against, indicating strong shareholder dissent.

08-06-2026

On June 4, 2026, Jordan Krugman resigned from all positions at Invesco Specialized Products, LLC and its affiliates, including his role as a member of the Board of Managers of the Sponsor, effective August 3, 2026. The Sponsor is considering his replacement. No financial impact is disclosed.

• · Resignation effective date: August 3, 2026
• · Mr. Krugman's resignation covers all positions at the Sponsor and affiliates
• · The Sponsor is actively considering a replacement

08-06-2026

OFA Group entered into Amendment No. 1 to the Conditional Waiver of Covenant with Atsion Opportunity Fund LLC – Series 1 on June 4, 2026, modifying the terms of a prior waiver related to a PIPE transaction. The amendment changes the remedy for default on a $1,000,000 commitment fee from immediate payment plus daily liquidated damages to conversion into up to 3,000,000 Class A ordinary shares, with the conversion price based on the volume-weighted average price on the day prior to the share transfer date. The issuance of these default shares is exempt from registration under Section 4(a)(2) of the Securities Act.

• · The Amendment was entered into on June 4, 2026, and the report was signed on June 5, 2026.
• · The Original Waiver was dated March 25, 2026, and the initial waiver of the Restriction was dated October 28, 2025.
• · The Atsion Purchase Agreement was entered into on July 22, 2025, with an effective date of July 14, 2025.
• · The conversion price for Default Shares is the volume-weighted average price of OFAL shares on the day immediately prior to the Share Transfer Date.
• · The issuance of Default Shares is exempt under Section 4(a)(2) of the Securities Act of 1933.

08-06-2026

On June 4, 2026, Jordan Krugman notified the Invesco CurrencyShares Canadian Dollar Trust of his resignation from all positions at the Sponsor, Invesco Specialized Products, LLC, and its affiliates, including his role on the Board of Managers, effective August 3, 2026. The Sponsor is currently considering a replacement. No financial impact or performance data is provided in this filing.

• · Resignation effective date: August 3, 2026.
• · Filing date: June 8, 2026; event date: June 4, 2026.
• · Sponsor is actively considering a replacement for Mr. Krugman.

08-06-2026

Noble Romans Inc. reported a strong turnaround in FY 2025 (year ended December 31, 2025), swinging from a net loss of $3,174 in FY 2024 to net income of $1,173,224. Total revenue grew 8.7% to $16.5M, driven by franchising revenue up 12.1% and non-traditional restaurant revenue up 26.4%. However, cash decreased 24.9% to $533,670 and the company's non-traditional restaurant segment remained unprofitable, with a negative margin contribution of $57,147.

• · Non-traditional restaurant segment had a negative margin contribution of $57,147 in FY 2025, slightly improved from -$47,072 in FY 2024.
• · The company's cash balance declined to $533,670 as of December 31, 2025 from $710,227 a year earlier.
• · Current portion of Corbel loan payable surged 413% to $5,470,824, and convertible subordinated notes increased from $0 to $575,000, contributing to a 147% rise in total current liabilities to $8,198,440.
• · Depreciation and amortization expense decreased 21.4% to $392,948.
• · General and administrative expenses declined 12.7% to $2,336,422.
• · Interest expense decreased 18.4% to $1,336,773.
• · Cost of new warrants issued in FY 2025 was $469,542, which was $0 in FY 2024.
• · Net change in warrant-related earnings effect was a loss of $521,978 in FY 2025 versus a small gain of $1,828 in FY 2024.
• · Diluted income per share was $0.04 in FY 2025, up from $0.00 in FY 2024.
• · Company-owned restaurant margin improved from 9.2% to 10.1%.
• · Franchising margin improved from 69.3% to 72.5%.

08-06-2026

Clean Energy Technologies, Inc. (CETY) entered into a subordinated business loan and security agreement on May 27, 2026, with Agile Capital Funding, LLC and Agile Lending, LLC for a term loan. The loan proceeds will be used to pay off an existing balance of $24,546.64 and fund general business requirements. The agreement includes a make-whole premium on prepayments and a default interest rate increase of 5.00%.

• · The loan is subordinated and secured by a security interest in the borrower's collateral.
• · Borrower must pay a make-whole premium equal to all interest that would have been paid through the Maturity Date upon any prepayment.
• · Interest is computed on a 360-day year basis.
• · The loan may not be reborrowed once repaid.
• · Borrower represents that there is no pending litigation involving more than $500,000.

08-06-2026

Catheter Precision, Inc. (VTAK) entered into a Securities Purchase Agreement on June 7, 2026, to purchase 2,941,176 shares of Volato Group, Inc. (SOAR) at $0.34 per share for an aggregate purchase price of $1,000,000 in a private placement. As of June 5, 2026, the market value of these shares was approximately $1,000,000, and Volato also agreed to deliver freely tradeable equity securities of a third-party entity valued at approximately $1,100,000. However, the company cautioned there is no guarantee it will realize these current values through future sales.

• · The closing of the private placement is subject to customary conditions including accuracy of representations and warranties, performance of covenants, and absence of a Material Adverse Effect with respect to Volato.
• · Volato agreed to file a registration statement on Form S-3 covering resale of the shares within 10 calendar days of the Registration Rights Agreement and use best efforts to have it declared effective promptly.
• · The Registration Rights Agreement includes customary provisions for registration procedures, expenses, liquidated damages, and indemnification.

08-06-2026

SUNation Energy, Inc. entered into a securities purchase agreement on June 7, 2026, to sell 2,390,000 shares of common stock at $1.13 per share, raising gross proceeds of $2,700,700. The offering is exempt from registration under Section 4(a)(2) and Rule 506, and the company expects to close on June 9, 2026, using net proceeds for working capital and general corporate purposes. Concurrently, the company entered into a registration rights agreement and a placement agency agreement with Maxim Group LLC, which will receive a 4.5% cash fee on gross proceeds plus $45,000 in expense reimbursement.

• · The offering includes no warrants and no price adjustment features.
• · Beneficial ownership limitation set at 4.99% (or 9.99% at holder's option) with ability to increase upon 61 days' notice.
• · Placement agency agreement dated June 5, 2026, with exclusive engagement until completion of offering.
• · Company responsible for all registration expenses under the Registration Rights Agreement.

08-06-2026

Volato Group announced a $2.2 million strategic investment led by Catheter Precision and other institutional investors, strengthening its balance sheet as it pivots to an AI-focused strategy. The company is evaluating two non-binding LOIs for AI infrastructure and power generation transactions, but no definitive agreements exist and the M2i Global transaction was recently terminated. While the investment provides near-term liquidity, the AI strategy remains highly speculative with no guaranteed outcomes.

• · The investment is in restricted common stock and subject to customary closing conditions, including NYSE American authorization of a supplemental listing application.
• · Volato owns Parslee, an AI software platform focused on deterministic document intelligence, and is developing Volato AI for aviation-specific AI agents.
• · The M2i Global transaction was recently terminated, but Volato believes this does not affect its NYSE American compliance plan.
• · No definitive agreements have been executed for the AI infrastructure opportunities, and there is no assurance either will result in a completed transaction.
• · Catheter Precision becomes Volato's largest shareholder as a result of this investment.

08-06-2026

Nurix Therapeutics announced a global collaboration with Roche to co-develop and co-commercialize bexobrutideg, a potential best-in-class BTK degrader, across malignant hematology, immunology, and neurology. Nurix will receive an upfront cash payment of $700 million and is eligible for up to $2.3 billion in milestones, with profits and losses shared equally in the U.S. and royalties on ex-U.S. sales. The collaboration includes a robust clinical development plan, but Nurix faces risks from sharing 40% of development costs and the need to establish a U.S. commercialization infrastructure.

• · Development costs shared 40% Nurix, 60% Roche.
• · U.S. profits and losses split equally.
• · Nurix eligible for low- to high-teens royalties on ex-U.S. sales.
• · Bexobrutideg is an oral, brain-penetrant BTK degrader targeting wild-type and mutant BTK.
• · Phase 2 trials planned in multiple sclerosis (MS) and chronic spontaneous urticaria (CSU).
• · Goldman Sachs acted as exclusive financial advisor to Nurix.

08-06-2026

T1 Energy Inc. (TE-WT) entered into a definitive agreement to acquire KORE Power Inc., a BESS and software solutions provider, for a total enterprise value of approximately $32 million, comprising equity, cash, and debt assumption. The deal includes $9.6 million in closing consideration paid in common stock, plus potential earn-outs of up to $9.6 million for FY2026 and FY2027 and an additional $5.5 million in stock contingent on a receivable payment. The shares will be issued in a private placement exempt from registration under Section 4(a)(2) of the Securities Act.

• · The number of shares for closing consideration and earn-outs will be determined by the volume-weighted average price (VWAP) over a 10-trading day observation period prior to issuance.
• · The transaction is expected to close in the second quarter of 2026, subject to customary conditions.
• · The shares are issued under the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933.
• · The company's common stock (TE) and warrants (TE WS) are listed on the New York Stock Exchange.

08-06-2026

AmeriServ Financial, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting to be held virtually on July 23, 2026. The company reported net income of $1.8 million ($0.11 EPS) for Q1 2026, down 6.0% from $1.9 million ($0.12 EPS) in Q1 2025, though net interest income improved by $897,000 due to a 25-basis-point margin expansion. The filing also discloses ongoing shareholder engagement, governance enhancements, and an expanded strategic partnership with SB Value Partners.

• · Net interest income represents approximately 73% of total revenue.
• · 53% of outstanding shares were contacted and 33% engaged in post-2025 Annual Meeting shareholder outreach.
• · The company eliminated cumulative voting in director elections and amended bylaws for market-standard proxy access.
• · The Compensation Committee engaged Pearl Meyer as independent compensation consultant.
• · Say-on-Pay results have been low since 2023, attributed to lack of disclosure on shareholder engagement rather than pay-for-performance misalignment.
• · The expanded relationship with SB Value Partners was announced in January 2026 with an amended consulting agreement focusing on operational efficiency, wealth management business development, and strategic initiatives.
• · Annual Meeting will be held virtually on July 23, 2026 at 1:30 p.m. ET.
• · Record Date for voting is May 8, 2026.

08-06-2026

Twenty One Capital, Inc. (XXI) appointed Paul S. Lalljie as an independent director and audit committee member, restoring compliance with NYSE and SEC audit committee independence requirements after SoftBank representatives stepped down in connection with Tether International's acquisition of SoftBank's stake on May 19, 2026. The company holds over 43,500 bitcoin and aims to build a Bitcoin-native public company. While the appointment strengthens governance, the departure of SoftBank representatives and the audit committee vacancy highlight recent board instability.

• · The appointment follows the May 19, 2026 closing of Tether International's acquisition of SoftBank Group's stake in Twenty One.
• · SoftBank's representatives on the Board stepped down, including one audit committee member, causing a vacancy that triggered NYSE notification.
• · Paul Lalljie currently serves as Member of the Supervisory Board and Audit Committee Chair at Bitdefender.
• · He previously served as CEO and CFO of 2U and CFO of Neustar.
• · Twenty One's strategy includes Bitcoin treasury, financial services, mining, and capital markets for recurring revenue and long-term Bitcoin accumulation.

08-06-2026

Cullinan Therapeutics announced initial Phase 1 clinical data from its OUTRACE trials for CLN-978 in treatment-refractory rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) at the EULAR congress. In SLE, 71% of evaluable patients achieved a ≥4-point hSLEDAI reduction and 5 achieved DORIS remission, while in RA, disease activity improved in 71% of patients with one DAS28-ESR remission. However, CRS events occurred in 38% of patients (11/29), including one Grade 3 case at the highest dose (45 μg), leading to discontinuation of that cohort.

• · Dose levels investigated ranged from 10 μg to 45 μg across 5 cohorts in SLE and 3 cohorts in RA.
• · In SLE, all lab markers (anti-dsDNA, UPCR, C3, C4) improved in patients with baseline abnormalities.
• · CLN-978 reduced RA autoantibody levels without impact on protective vaccine titers.
• · Dose-dependent B cell depletion observed in lymph node and synovial tissue in RA.
• · No immune effector cell-associated neurotoxicity syndrome (ICANS) was observed.
• · Enrollment to the 45 μg cohort was discontinued; additional step-up dosing may be implemented.

08-06-2026

Oscar Health, Inc. announced its participation in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, where it will provide a business update and reaffirm its full year 2026 guidance previously issued on February 10, 2026. The filing contains no new financial data or performance metrics, only forward-looking statements and a cautionary note regarding risks.

• · The fireside chat is scheduled for June 8, 2026 at approximately 11:20 AM ET.
• · A live audio webcast will be available via the Investor Relations page at ir.hioscar.com, with a replay available for approximately 90 days.
• · The company reaffirms its full year 2026 guidance as provided in its financial results press release dated February 10, 2026.
• · The filing includes a cautionary note regarding forward-looking statements and references risk factors in the Annual Report on Form 10-K for the year ended December 31, 2025 and the Quarterly Report on Form 10-Q for the period ended March 31, 2026.

08-06-2026

Positano Wealth Management Ltd filed its quarterly 13F-HR for the period ending March 31, 2026, reporting a total of 24 equity holdings with an aggregate market value of approximately $135.2 million. The portfolio is concentrated in large-cap technology and financial stocks, with top holdings including Alphabet Inc. ($21.2M), NVIDIA Corporation ($21.2M), Microsoft Corp. ($16.5M), Visa Inc. ($14.8M), and Chubb Ltd ($13.3M). No period-over-period comparisons are available as this is a single-period filing.

• · The filing was signed by Tai Ka Yan, Senior Manager, on June 8, 2026.
• · All 24 positions are held with sole voting and dispositive power; no shared or non-dispositive holdings are reported.
• · The largest position by share count is Hewlett Packard Enterprise Co. with 180,389 shares valued at $4.3M.
• · The smallest position by value is Arthur J. Gallagher & Co. at $13,861 (64 shares).
• · The portfolio includes a mix of U.S. and foreign issuers (e.g., Autohome, Futu Holdings, TSMC).

08-06-2026

Genco Shipping & Trading Limited filed Amendment No. 10 to its Schedule 14D-9, responding to Diana Shipping Inc.'s unsolicited tender offer to purchase all Genco common stock for $24.80 per share in cash. The amendment adds exhibits including LinkedIn advertisements and a company statement dated June 8, 2026, but does not disclose any change in the board's recommendation or new financial data.

• · The amendment is the 10th amendment to the original Schedule 14D-9 filed on May 15, 2026.
• · New exhibits include LinkedIn advertisements (June 5, 2026), a LinkedIn post (June 8, 2026), and a company statement (June 8, 2026).
• · The filing does not indicate any change in the board's recommendation regarding the tender offer.

08-06-2026

Aeries Technology, Inc. filed its 10-K annual report for the fiscal year ended March 31, 2026, reporting a net income of $3.47M, a sharp turnaround from a net loss of $21.60M in the prior year. While the company achieved positive net income and expanded gross margins to 25%, total revenue remained essentially flat at $70.01M (down 0.3% YoY), with North America revenue declining 4.0% to $62.87M. Adjusted EBITDA improved to $8.31M (11.9% margin) versus a negative $4.65M (6.6% margin) in FY2025, but the improvement was driven largely by a 72% reduction in SG&A expenses from $45.49M to $12.78M, which included significant decreases in stock-based compensation and transaction costs.

• · Revenue from Asia Pacific and Other segment grew 51.5% to $7.14M, partially offsetting the 4.0% decline in North America ($62.87M from $65.49M).
• · Cost of Revenue decreased slightly by 1.4% to $52.72M from $53.48M.
• · SG&A expenses were slashed by 71.9% to $12.78M, primarily due to reductions in stock-based compensation ($12.75M to not separately disclosed) and Business Combination/M&A costs ($7.0M to $1.0M).
• · Depreciation and amortization fell to $0.84M from $1.38M.
• · The company swung from an operating loss of $28.77M to an operating income of $4.52M.
• · Net income attributable to shareholders was $2.55M versus a loss of $19.71M in the prior year.
• · Adjusted EBITDA turned positive at $8.31M (11.9% margin) from negative $4.65M (6.6% margin).
• · The company disclosed that clients have the right to terminate auto-renewal contracts, creating revenue risk.
• · There is risk of adverse effects from uncollected receivables, particularly in the Middle East and Asia Pacific region.
• · The company flagged dilution risk from registered shares on Form S-1 (333-276173) and additional equity issuances.

08-06-2026

Ciena Corporation announced a $2.0 billion convertible senior notes offering due 2031, with an option for initial purchasers to buy an additional $300 million. The company plans to use net proceeds to repay approximately $1.14 billion of its existing senior secured term loan, repurchase up to $140 million of common stock, and fund general corporate purposes including supply chain investments. Concurrently, Ciena expects to amend its credit agreement to extend the revolving facility maturity to October 24, 2030 and adjust interest rate terms, with the offering and amendment being cross-conditional.

• · The notes will be fully and unconditionally guaranteed by each wholly-owned domestic subsidiary that currently or in the future guarantees the company's 4.00% senior notes due 2030.
• · The convertible note hedge and warrant transactions are expected to be entered into with one or more initial purchasers or affiliates and/or other financial institutions.
• · The Credit Agreement Amendment extends the revolving facility maturity from October 24, 2028 to October 24, 2030.
• · The credit spread adjustment applicable to SOFR-based borrowings under the revolving facility will be removed.
• · Daily SOFR will be added as an interest rate option for borrowings under the revolving facility.
• · The commitment fee on the unused portion of the revolving facility will range from 0.20% to 0.30% per annum based on the Total Net Leverage Ratio.
• · The effectiveness of the Credit Agreement Amendment is conditioned upon repayment in full of the Existing Term Loan.

08-06-2026

Palladyne AI Corp. announced a memorandum of understanding (MOU) with Israel Aerospace Industries (IAI) for exclusive rights to manufacture and market certain loitering munitions systems (HAROP, HARPY, Mini-HARPY) to the U.S. government. The agreement includes a license to IAI's intellectual property, requires Palladyne to establish a U.S. assembly line at its own cost, and provides for a market-rate royalty on sales with no upfront payments. The MOU has a potential term of up to ten years, subject to milestone achievement.

• · The MOU grants Palladyne exclusive rights to manufacture and market certain IAI loitering munitions systems to the U.S. government.
• · The first systems covered are HAROP, HARPY, and Mini-HARPY.
• · Palladyne must establish and operate a U.S. assembly line at its sole cost and expense.
• · Palladyne will pay IAI a market-rate royalty equal to a percentage of sales; no other upfront royalty payments are due.
• · The MOU term can be up to ten years, subject to achievement of milestones.
• · The government of Israel retains the right to sell Systems directly to the U.S. government.
• · An investor call is scheduled for June 9, 2026.
• · The company is an emerging growth company.

08-06-2026

Duluth Holdings reported Q1 FY2026 results with a net loss of $10.0M, improving from a $15.3M loss in the prior year, while gross margin expanded 540 bps to 57.4% and adjusted EBITDA rose $6.4M to $2.6M. However, net sales declined 4.0% to $98.6M, driven by an 8.7% drop in direct-to-consumer sales amid reduced promotional activity, partially offset by a 3.3% increase in retail store sales. The company raised its fiscal 2026 adjusted EBITDA guidance to $28-$32M while affirming net sales guidance of $540-$560M.

• · SG&A expenses decreased $3.4M or 5.2% to $61.8M, driven by leverage on variable expenses from fulfillment network efficiencies and reduction in personnel expenses.
• · Direct-to-consumer net sales declined 8.7% due to declines in web traffic and web conversion from reduced promotional activity, partially offset by higher average order values.
• · Retail store net sales increased 3.3% driven by higher average order values in comparable stores and two new stores opened in Q3 FY2025.
• · Gross margin expansion was primarily driven by increased average unit retail prices from reduced promotional activity and improved product costs from the direct to factory sourcing initiative, partially offset by tariff costs.
• · Cash and cash equivalents decreased to $6.1M from $16.3M at the end of FY2025 and from $8.6M a year ago.
• · The company has $6.0M outstanding on its $100M ABL facility.
• · Adjusted EPS of ($0.20) excludes $2.7M in impairment charges and $1.4M in restructuring expenses, net of tax.
• · Fiscal 2026 guidance: net sales affirmed at $540-$560M; adjusted EBITDA raised from $26-$30M to $28-$32M; capex (including software hosting implementation costs) affirmed at ~$12M.
• · Conference call scheduled for June 8, 2026 at 9:30 am ET.

08-06-2026

Incyte Corporation announced on June 8, 2026 that it has entered into a definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of Star Therapeutics, LLC. No financial terms of the acquisition were disclosed in the filing.

• · The acquisition of Vega Therapeutics is a wholly owned subsidiary of Star Therapeutics, LLC.
• · No financial details, deal value, or expected closing timeline were provided in the filing.